1 vote
Foreign exchange gains and other income helped drug maker Ranbaxy Laboratories to post a 168 per cent rise in third-quarter net profit at Rs312.8 crore, compared to Rs116.6 crore a year earlier. Consolidated sales for the three months through September rose 9.7 per cent to Rs1,887.2 crore from Rs1,720.5 crore.